Literature DB >> 3008106

The organization of the human HPRT gene.

S H Kim, J C Moores, D David, J G Respess, D J Jolly, T Friedmann.   

Abstract

The organization of the X-linked gene for human hypoxanthine phosphoribosyltransferase (HPRT, EC 2.4.2.8.) has been determined by a combination of restriction endonuclease mapping, heteroduplex analysis and DNA sequence analysis of overlapping genomic clones. The entire gene is 42 kilobases in length and split into 9 exons. The sizes of the 7 internal exons and the exon-intron boundaries are identical to those of mouse HPRT gene. The 5' end of the gene lacks the prototypical 5' transcriptional regulatory sequence elements but contains extremely GC-rich sequences and five GC hexanucleotide motifs (5'-GGCGGG-3'). These structural features are very similar to those found in the mouse HPRT gene and to some of the regulatory signals common to a class of constitutively expressed "housekeeping" genes. Several transcriptional start sites have been identified by nuclease protection studies. Extensive sequence homology between the mouse and human genes is found in the 3' non-coding portion of the gene.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3008106      PMCID: PMC339724          DOI: 10.1093/nar/14.7.3103

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  40 in total

1.  Heterogeneity at the 5' termini of mouse dihydrofolate reductase mRNAs. Evidence for multiple promoter regions.

Authors:  M McGrogan; C C Simonsen; D T Smouse; P J Farnham; R T Schimke
Journal:  J Biol Chem       Date:  1985-02-25       Impact factor: 5.157

2.  Transcriptional regulation of mouse dihydrofolate reductase in the cell cycle.

Authors:  P J Farnham; R T Schimke
Journal:  J Biol Chem       Date:  1985-06-25       Impact factor: 5.157

3.  A specific enzyme defect in gout associated with overproduction of uric acid.

Authors:  W N Kelley; F M Rosenbloom; J F Henderson; J E Seegmiller
Journal:  Proc Natl Acad Sci U S A       Date:  1967-06       Impact factor: 11.205

4.  The use of drug-resistant markers to study the hybridization of mouse fibroblasts.

Authors:  J W Littlefield
Journal:  Exp Cell Res       Date:  1966-01       Impact factor: 3.905

5.  Control of eukaryotic messenger RNA synthesis by sequence-specific DNA-binding proteins.

Authors:  W S Dynan; R Tjian
Journal:  Nature       Date:  1985 Aug 29-Sep 4       Impact factor: 49.962

6.  Enzyme defect associated with a sex-linked human neurological disorder and excessive purine synthesis.

Authors:  J E Seegmiller; F M Rosenbloom; W N Kelley
Journal:  Science       Date:  1967-03-31       Impact factor: 47.728

7.  Multiple specific contacts between a mammalian transcription factor and its cognate promoters.

Authors:  D Gidoni; W S Dynan; R Tjian
Journal:  Nature       Date:  1984 Nov 29-Dec 5       Impact factor: 49.962

8.  Faithful cell-cycle regulation of a recombinant mouse histone H4 gene is controlled by sequences in the 3'-terminal part of the gene.

Authors:  B Lüscher; C Stauber; R Schindler; D Schümperli
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

9.  Characterization and sequence of the promoter region of the human epidermal growth factor receptor gene.

Authors:  S Ishii; Y H Xu; R H Stratton; B A Roe; G T Merlino; I Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  1985-08       Impact factor: 11.205

10.  Adenosine deaminase: characterization and expression of a gene with a remarkable promoter.

Authors:  D Valerio; M G Duyvesteyn; B M Dekker; G Weeda; T M Berkvens; L van der Voorn; H van Ormondt; A J van der Eb
Journal:  EMBO J       Date:  1985-02       Impact factor: 11.598

View more
  34 in total

1.  Transcriptional selectivity in early mouse embryos: a qualitative study.

Authors:  C Bonnerot; M Vernet; G Grimber; P Briand; J F Nicolas
Journal:  Nucleic Acids Res       Date:  1991-12       Impact factor: 16.971

Review 2.  Artificial chromosome-based transgenes in the study of genome function.

Authors:  Jason D Heaney; Sarah K Bronson
Journal:  Mamm Genome       Date:  2006-08-04       Impact factor: 2.957

3.  Short DNA fragments induce site specific recombination in mammalian cells.

Authors:  K Hunger-Bertling; P Harrer; W Bertling
Journal:  Mol Cell Biochem       Date:  1990-02-09       Impact factor: 3.396

4.  Lesch-Nyhan syndrome: molecular investigation of three French Canadian families using a hypoxanthine-guanine phosphoribosyltransferase cDNA probe.

Authors:  D Sinnett; L Lavergne; S B Melançon; L Dallaire; M Potier; D Labuda
Journal:  Hum Genet       Date:  1988-12       Impact factor: 4.132

5.  Do exons code for structural or functional units in proteins?

Authors:  T W Traut
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

6.  Regulatory elements in the introns of the human HPRT gene are necessary for its expression in embryonic stem cells.

Authors:  L H Reid; R G Gregg; O Smithies; B H Koller
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

7.  Effect of 5-azacytidine on gene expression in marrow stromal cells.

Authors:  D F Andrews; J Nemunaitis; C Tompkins; J W Singer
Journal:  Mol Cell Biol       Date:  1989-06       Impact factor: 4.272

8.  Nucleosomes are translationally positioned on the active allele and rotationally positioned on the inactive allele of the HPRT promoter.

Authors:  C Chen; T P Yang
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

9.  Role of the promoter in maintaining transcriptionally active chromatin structure and DNA methylation patterns in vivo.

Authors:  Sung-Hae Lee Kang; Christine Mione Kiefer; Thomas P Yang
Journal:  Mol Cell Biol       Date:  2003-06       Impact factor: 4.272

10.  Efficient cDNA cloning by direct phenotypic correction of a mutant human cell line (HPRT-) using an Epstein-Barr virus-derived cDNA expression vector.

Authors:  P B Belt; W Jongmans; J de Wit; J H Hoeijmakers; P van de Putte; C Backendorf
Journal:  Nucleic Acids Res       Date:  1991-09-25       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.